Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype
- 19 September 2015
- journal article
- research article
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 17 (1) , 71-77
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cutaneous T‐cell lymphoma: 2014 Update on diagnosis, risk‐stratification, and managementAmerican Journal of Hematology, 2014
- New Insights into Associated Co-morbidities in Patients with Cutaneous T-cell Lymphoma (Mycosis Fungoides)Acta Dermato-Venereologica, 2013
- Age, Race, Sex, Stage, and Incidence of Cutaneous LymphomaClinical Lymphoma Myeloma and Leukemia, 2012
- Increased Malignancy Risk in the Cutaneous T-Cell Lymphoma Patient PopulationClinical Lymphoma Myeloma and Leukemia, 2008
- Second Lymphomas and Other Malignant Neoplasms in Patients With Mycosis Fungoides and Sézary SyndromeArchives of Dermatology, 2007
- WHO-EORTC classification for cutaneous lymphomasBlood, 2005
- Increased Risk of Secondary Cancers in Patients with Primary Cutaneous T Cell LymphomaJournal of Investigative Dermatology, 2000
- Secondary Malignant Neoplasms in 71 Patients With Sézary SyndromeArchives of Dermatology, 1999
- Prognosis in cutaneous T-cell lymphoma by skin stage: Long-term survival in 489 patientsJournal of the American Academy of Dermatology, 1999
- Risk of second malignancy after cutaneous T-cell lymphomaCancer, 1989